The city of Sioux Falls, South Dakota, currently has 1 active clinical trials seeking participants for Pulmonary Fibrosis research studies.
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Recruiting
Ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and efficacy of oral ifetroban will be assessed in patients with IPF.
Gender:
ALL
Ages:
40 years and above
Trial Updated:
04/14/2025
Locations: Avera Research Institute, Sioux Falls, South Dakota
Conditions: Idiopathic Pulmonary Fibrosis